• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Resverlogix Corp

+ Add to Watchlist

RVX:CN

0.7500 CAD 0.0100 1.35%

As of 14:47:24 ET on 08/21/2014.

Snapshot for Resverlogix Corp (RVX)

Open: 0.7700 Day's Range: 0.7500 - 0.7700 Volume: 45,240
Previous Close: 0.7400 52wk Range: 0.4350 - 1.1600 1-Yr Rtn: +20.97%

Stock Chart for RVX

No chart data available.
  • RVX:CN 0.7500
  • 1D
  • 1M
  • 1Y
0.7400
Interactive RVX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RVX

Current P/E Ratio (ttm) 1.2927
Estimated P/E(04/2014) -
Relative P/E vs. SPTSX 0.0645
Earnings Per Share (USD) (ttm) 0.5300
Est. EPS (USD) (04/2014) -
Est. PEG Ratio -
Market Cap (M CAD) 63.97
Shares Outstanding (M) 85.29
30 Day Average Volume 48,321
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RVX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RVX

Resverlogix Corp. is a biotechnology company focused on developing therapies for unmet medical needs. The Company concentrates on cardiovascular disease, cancer, and fibrotic conditions.

Donald J McCaffreyPresident/CEO/SecretaryAaron Bradley Cann "Brad"Chief Financial Officer
Norman WongChief Scientific OfficerKenneth LebiodaSenior VP:Bus & Corporate Dev
More Company Profile & Key Executives for RVX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil